COLCOM produces DrendriGraft of Lysine (DGL), nanoscale macromolecules, and market them worldwide. DGL have large capacities in various biological applications (targeted drug & gene delivery, biomaterials, medical imaging etc.) and support greater progress in different sectors as the Environmental sphere and Life sciences, where companies are thinking about involving nanotechnologies in their business. COLCOM's concern is to guarantee to its partners the ownership of the results with an exclusive use and commercial exploitation of the developed compounds. This particular positioning brings especially win-win situations due to its mastery of the synthesis process and the know-how that we have in terms of customized implementation of our core technology. For any question or information, feel free to contact us at info@colcom.eu and visit our website!